Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|
| TGTX | TG THERAPEUTICS INC | $5.82B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CORT | CORCEPT THERAPEUTICS INC | $9.29B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CRMD | CORMEDIX INC | $769.13M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $2.85B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HALO | HALOZYME THERAPEUTICS INC | $8.07B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KRYS | KRYSTAL BIOTECH INC | $5.31B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ARGX | ARGENX SE | $48.83B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| INVA | INNOVIVA INC | $1.10B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VCEL | VERICEL CORP | $1.64B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RPRX | ROYALTY PHARMA PLC | $21.04B | 2.41% | 37.20% | $0.2200 | $0.87 | 54% | 0 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $1.49B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| INCY | INCYTE CORP | $16.96B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| EXEL | EXELIXIS INC | $10.79B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| GYRE | GYRE THERAPEUTICS INC | $713.68M | N/A | 0.00% | $20.0200 | N/A | N/A | 0 | ||
| ADMA | ADMA BIOLOGICS INC | $3.50B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MDXG | MIMEDX GROUP INC | $1.07B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.57B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ATRA | ATARA BIOTHERAPEUTICS INC | $101.20M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TECH | BIO-TECHNE CORP | $9.79B | 0.51% | 68.10% | $0.0800 | $0.32 | 11% | 1 | ||
| VCYT | VERACYTE INC | $2.82B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $10.64B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $103.40B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| GMAB | GENMAB A | $21.53B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $2.55B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NVO | NOVO NORDISK A S | $266.25B | 1.84% | 41.40% | $1.0992 | $1.10 | 43% | 9 | ||
| MNKD | MANNKIND CORP | $1.77B | N/A | 0.00% | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.